Stem cells are the building blocks used to make all the other types of cells in the body. When stem cells are in the right place (the body or a lab), they can divide and make daughter cells. It’s important to know that embryonic stem cells are taken from early-stage embryos, made when an egg and sperm are put together in a lab to make a baby (Mardpour et al., 2018). We know some people don’t like embryonic stem cells, while others see their value in medicine. Here, we’ll briefly talk about some of the benefits it might have for you.
The first thing that could come from studying embryonic stem cells is a better understanding of what makes people sick. By watching how stem cells change into cells for bone, heart muscle, neurons, and other organs and tissues, scientists may be able to learn more about the causes of many diseases and disorders. The second possible benefit is that, as research continues, I’m becoming more sure that it will be possible to replace diseased cells in the future (Mardpour et al., 2018). Third, researchers may be able to test new medicines to see how safe and effective they are.
As a side note, I’d like to bring up the efforts that are now being made to stop irresponsible research practices and punish those who do them. I want to point out that the NIH has a policy and procedures to help fund studies like this. These policies and procedures help ensure that any such study is done in a way that is ethical, scientific, and legal (Chen & Li, 2021). To add to what I said before, I want to stress that the stem cells had to come from an embryo made only for reproduction, that informed consent had to be obtained for the donation of the embryo, and that the donation of the embryo was not in exchange for money. In my answer, I’ll talk about some of the most common criticisms so we can learn more.
I’m aware that many people’s views on the ethical and theological implications of embryonic stem research have varied. I know that some individuals also feel that there’s a lot of promise in embryonic stem cell research since only this cell has the flexibility for mending damaged nerves, organs, and tissues and healing hundreds of severe illnesses (Chen & Li, 2021). (Chen & Li, 2021). The purpose of today’s discussion is to examine these criticisms so that we may get a solid grasp of the topic and, perhaps, come to terms with it.
Some disagree with embryonic stem cell research because it is cruel to destroy a human embryo with the potential to develop into a newborn only to get a small sample of stem cells (Eguizabal et al., 2019). The vast majority of people can relate to this, I’m sure. However, I’d like to give us time to figure things out for ourselves. We all know why this is a problem: no one disputes that embryos can grow into human beings; if inserted into a woman’s uterus at a suitable hormonal period, an embryo may implant, develop into a fetus, and eventually give birth to a healthy, living kid (Horner et al., 2018). My investigation into the topic has led me to conclude that, if successful, embryonic stem cell research may lead to significant medical advances. The world would do well to consider the topic’s molarity and virtues seriously.
Many people believe that the opposition to embryonic stem cell research stems from the fact that no proof of treatment or even the possibility of a cure has been discovered to justify the destruction of the beginning of life, a human embryo (Horner et al., 2018). I can attest that the discovery of this method of treating illness has given the human race reason to be optimistic. The only way to determine whether the study can succeed without funding is to do the research. Since this has not been the case and the study has not been adequately funded, it is impossible to say whether or not it is essential that the initiative be continued. It has become clear to me that if the study is well financed, we may be able to determine whether or not it is worth our time to pursue.
Another concern that has been raised about this investigation is that it may pave the way for harmful experiments using the cloning or genetic editing of human organs, tissues, or embryos if such techniques were legalized. This may be correct, but I think we need to perform an additional investigation to determine the whole truth.
However, I am aware that many disagree with me and argue that embryonic stem cell research is an inefficient and unethical approach to advancing scientific knowledge since it diverts resources from other, more promising lines of inquiry (Horner et al., 2018). The study seems to indicate that this is the case, but I can’t help but think that other studies are being undertaken that go against morals and global peace to extract even more cash, like nuclear warheads.
Despite the presented evidence, the issue of whether morals and ethics are more important than the potential health advantages of embryonic stem cell research remains open. This is a question that only time will answer, and I think that the choice that will be taken will be of great human benefit for the decades to come.
References
Chen, J., & Li, W. (2021). Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing. Stem Cell Reports, 16(8), 1868-1873. https://doi.org/10.1016/j.stemcr.2021.07.005
Eguizabal, C., Aran, B., Chuva de Sousa Lopes, S. M., Geens, M., Heindryckx, B., Panula, S., Popovic, M., Vassena, R., & Veiga, A. (2019). Two decades of embryonic stem cells: A historical overview. Human Reproduction Open, 2019(1). https://doi.org/10.1093/hropen/hoy024
Horner, C., Tenenbaum, E., Sipp, D., & Master, Z. (2018). Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions? npj Regenerative Medicine, 3(1). https://doi.org/10.1038/s41536-018-0043-6
Mardpour, S., Hassani, S., Mardpour, S., Sayahpour, F., Vosough, M., Ai, J., Aghdami, N., Hamidieh, A. A., & Baharvand, H. (2018). Extracellular vesicles derived from human embryonic stem cell‐MSCs ameliorate cirrhosis in thioacetamide‐induced chronic liver injury. Journal of Cellular Physiology, 233(12), 9330-9344. https://doi.org/10.1002/jcp.26413
write